Nome | Settore | Analyst Name | Analyst Job Title | Rating Quantitativo | Data | |
---|---|---|---|---|---|---|
Novartis AG ADR | Salute | Jay Lee | Senior Equity Analyst | 29/04/2025 | ||
Novartis AG Registered Shares | Salute | Jay Lee | Senior Equity Analyst | 29/04/2025 | ||
AstraZeneca PLC | Salute | Jay Lee | Senior Equity Analyst | 29/04/2025 | ||
AstraZeneca PLC ADR | Salute | Jay Lee | Senior Equity Analyst | 29/04/2025 | ||
Incyte Corp | Salute | Rachel Elfman | Equity Analyst | 29/04/2025 | ||
Labcorp Holdings Inc | Salute | Debbie Wang | Senior Equity Analyst | 29/04/2025 | ||
Pfizer Inc | Salute | Karen Andersen | Director | 29/04/2025 | ||
Tenet Healthcare Corp | Salute | Julie Utterback | Senior Equity Analyst | 29/04/2025 | ||
Alibaba Health Information Technology Ltd | Salute | Kai Wang | Senior Equity Analyst | 29/04/2025 | ||
JD Health International Inc | Salute | Kai Wang | Senior Equity Analyst | 29/04/2025 | ||
Guangzhou Kingmed Diagnostics Group Co Ltd Class A | Salute | Yurou Zheng | Equity Analyst | 29/04/2025 | ||
Medpace Holdings Inc | Salute | Rachel Elfman | Equity Analyst | 29/04/2025 | ||
Daiichi Sankyo Co Ltd | Salute | Jay Lee | Senior Equity Analyst | 29/04/2025 | ||
Siegfried Holding AG | Salute | Rachel Elfman | Equity Analyst | 28/04/2025 | ||
Tilray Brands Inc | Salute | Kristoffer Inton | Strategist | 28/04/2025 | ||
Merck KGaA | Salute | Max Jousma | Equity Analyst | 28/04/2025 | ||
Merck KGaA ADR | Salute | Max Jousma | Equity Analyst | 28/04/2025 | ||
Revvity Inc | Salute | Julie Utterback | Senior Equity Analyst | 28/04/2025 | ||
Telix Pharmaceuticals Ltd Ordinary Shares | Salute | Shane Ponraj | Equity Analyst | 28/04/2025 | ||
Chugai Pharmaceutical Co Ltd | Salute | Jay Lee | Senior Equity Analyst | 25/04/2025 |